Palomar, Syneron settle patent spat for $31M plus royalties | Legal News
September 16, 2011 by MassDevice staff
Syneron Medical settles the patent spat with Palomar Medical Technologies it inherited with a buyout of Candela Corp last year, agreeing to pay $31 million plus royalties to license patents covering PMTI's hair-removal technology; plus, Merge Healthcare slips insurance lawsuit over Amicas deal; Caliper shareholders sue to block $600M PerkinElmer buyout; and Saint-Gobain takes it to the Supremes.
Syneron Medical Ltd. (NSDQ:ELOS) agreed to pony up $31 million plus royalties for the rights to a pair of Palomar Medical Technologies (NSDQ:PMTI) patents for laser- and light-based hair removal technologies, ending a long-running legal battle.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
- How to simplify consents
Navigation
NEWS
Yale study of Medtronic's Infuse shows it's equivalent to bone graft, but studies were biased
A pair of independent analyses of patient-level data commissioned by a Yale University open data...
J&J's Synthes unit wins $16M ruling in patent fight with Globus Medical
A Delaware jury sides with Johnson & Johnson's DePuy-Synthes subsidiary in a patent spat over 3...
Aneurysm: Covidien touts pivotal study on Pipeline embolization device
Results of pivotal study on Covidien subsidiary eV3's Pipeline cerebral aneurysm device, published in...
ForSight Vision5 gets new CEO, closes $9.3M funding round
Delphi Ventures' John Maroney joins ForSight Vision5 as president, CEO & Director as the...
